| Bid Price | 3.80p | High Price | 4.08p |
|---|
| Ask Price | 4.10p | Low Price | 3.80p |
|---|
| Open Price | 3.90p | Spread | 7.32% |
|---|
| Prev Close | 3.90p | Volume | 520,577 |
|---|
Roquefort Therapeutics PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Dec 20, 2024 | 3.90 | 4.08 | 3.80 | 3.95 | 520,577 |
| Dec 19, 2024 | 3.85 | 4.00 | 3.72 | 3.90 | 586,180 |
| Dec 18, 2024 | 4.30 | 4.20 | 3.80 | 3.85 | 1,422,912 |
| Dec 17, 2024 | 4.50 | 4.55 | 4.10 | 4.30 | 336,441 |
| Dec 16, 2024 | 4.50 | 4.67 | 4.33 | 4.50 | 854,114 |
Roquefort Therapeutics PLC Information
| Name | Roquefort Therapeutics PLC | Index | |
|---|
| ISIN | GB00BMDQ2T15 | Epic | ROQ |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SSQ3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 20,000 | Trading Status | Closed |
|---|
| Shares in Issue | 135.74 m | Prev Close | 3.90p |
|---|
| PE Ratio | | Market Cap | £5.36 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.097595 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.791677 | Quick Ratio | 0.791677 |
|---|
Roquefort Therapeutics PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 04/12/24 | TIN | Darrin Disley | NED | 9,146 @ £0.00 | £0.00 |
| 04/12/24 | TIN | Martin Evans | ED | 2,690 @ £0.00 | £0.00 |
| 04/12/24 | TIN | Trevor Reginald | CEO | 34,432 @ £0.00 | £0.00 |
| 02/08/23 | BUY | Darrin Disley | NED | 269,935 @ £0.07 | £19,840.00 |
| 12/07/23 | BUY | Stephen West | CH | 15,730 @ £0.06 | £983.00 |
| 12/07/23 | BUY | Stephen West | CH | 143,390 @ £0.06 | £8,948.00 |
| 26/06/23 | BUY | Stephen West | CH | 144,117 @ £0.07 | £9,944.00 |
| 26/06/23 | BUY | Simon Sinclair | NED | 35,921 @ £0.07 | £2,489.00 |
| 26/06/23 | BUY | Trevor Reginald | CEO | 1,350 @ £0.07 | £93.00 |
| 26/06/23 | BUY | Trevor Reginald | CEO | 2,600 @ £0.07 | £184.00 |
Roquefort Therapeutics PLC News
